
Opinion|Videos|June 28, 2024
CLL Treatment Landscape: Overview of BTK Inhibitors
A panel of experts provide an overview of BTK inhibitors for the treatment of patients with chronic lymphocytic leukemia.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- Provide an overview of the current landscape of treatment-naïve CLL treatment options. Where do the BTK inhibitors fit into this landscape?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Physical Activity, Vaccination May Protect Against Long COVID
2
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
3
Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations
4
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
5